Aspirin Combined With Ticagrelor or Clopidogrel in STEMI Patients With Diabetes Mellitus and Poor Glycemic Control Undergoing Primary PCI: A Multicenter Retrospective Cohort Study
Catheterization and Cardiovascular Interventions · 2026-04 · 107 (5) · 1562-1572
DOI: 10.1002/ccd.70503 ↗At a glance
Multizentrische Studie in Catheterization and Cardiovascular Interventions, published online on 2026-02-08. Written by Yan Liu and 5 co-authors. Institution: Department of Cardiology, National Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute, General Hospital of North…. Major MEDLINE topics: Ticagrelor, Clopidogrel, Platelet Aggregation Inhibitors, Aspirin. Cited 1 times so far (Crossref); 46 references. Funded by: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Mega Project on Major Infectious Disease Prevention.
Topics: Diabetes mellitus
Abstract (original language)
Background
The safety and efficacy of aspirin combined with ticagrelor or clopidogrel remain unclear in ST‐segment elevation myocardial infarction (STEMI) patients with Diabetes mellitus (DM) and poor glycemic control.
Aims
This study aims to assess the efficacy and safety of ticagrelor versus clopidogrel–based dual antiplatelet therapy in STEMI patients with DM and poor glycemic control undergoing pPCI.
Methods
We evaluated 2732 STEMI patients with DM and poor glycemic control who underwent primary percutaneous coronary intervention (pPCI) and were registered in the “Improving Care for Cardiovascular Disease in China‐Acute Coronary Syndrome (CCC‐ACS)” program between November 2014 and December 2019. Using propensity score matching (PSM) and cox proportional hazards regression, we compared the in‐hospital risk of major adverse cardiovascular events (MACCE), TIMI bleeding events, and net adverse clinical events (NACE) between patients receiving aspirin combined with either ticagrelor or clopidogrel.
Results
After PSM, the risk of in‐hospital MACCE (HR = 0.545, 95% CI: 0.321–0.926, p = 0.025), Cardiac death (HR = 0.380, 95% CI: 0.149–0.971, p = 0.043) and NACE (HR = 0.728, 95% CI: 0.560–0.947, p = 0.018) was significantly lower in the ticagrelor group compared with the clopidogrel group ( p < 0.05), while no significant difference was observed in the incidence of TIMI‐bleeding events between the two groups ( p > 0.05).
Conclusion
Among STEMI patients with DM and poor glycemic control undergoing pPCI, ticagrelor use was associated with a low rate of MACCE, without an excessive risk of bleeding. Trial Registration The information of clinical trial registration for CCC‐ACS project can be found at http://clinicaltrials.gov/study/NCT02306616 .
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, National Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
- School of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
ORCID profiles: Yan Liu, Xiaozeng Wang
Funding
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Mega Project on Major Infectious Disease Prevention
Cite
APA
Liu, Y., Liu, X., Sun, D., Gu, R., Li, M., & Wang, X. (2026). Aspirin Combined With Ticagrelor or Clopidogrel in STEMI Patients With Diabetes Mellitus and Poor Glycemic Control Undergoing Primary PCI: A Multicenter Retrospective Cohort Study. Catheterization and Cardiovascular Interventions, 107(5), 1562-1572. https://doi.org/10.1002/ccd.70503
Vancouver
Liu Y, Liu X, Sun D, Gu R, Li M, Wang X. Aspirin Combined With Ticagrelor or Clopidogrel in STEMI Patients With Diabetes Mellitus and Poor Glycemic Control Undergoing Primary PCI: A Multicenter Retrospective Cohort Study. Catheterization and Cardiovascular Interventions. 2026;107(5):1562-1572. doi:10.1002/ccd.70503
BibTeX
@article{Liu2026,
author = {Liu, Yan and Liu, Xue and Sun, Dongyuan and Gu, Ruoxi and Li, Meicen and Wang, Xiaozeng},
title = {Aspirin Combined With Ticagrelor or Clopidogrel in STEMI Patients With Diabetes Mellitus and Poor Glycemic Control Undergoing Primary PCI: A Multicenter Retrospective Cohort Study},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
volume = {107},
number = {5},
pages = {1562--1572},
doi = {10.1002/ccd.70503}
}
EUVIMED